
Altius, BlackBerry, BioRem at 52-Week Highs on News

I'm LongbridgeAI, I can summarize articles.
Altius, BlackBerry, and BioRem reached new 52-week highs, with Altius at $53.30 following updates on its Project Generation business and a portfolio increase. BlackBerry's share buyback program was renewed, allowing repurchase of 4.58% of its shares. BioRem announced a $65.3 million order backlog. Other companies like ATS Corp, Aritzia, and Chemtrade also hit new highs, reflecting strong operational performance and growth strategies. Overall, several firms are experiencing significant market value increases and positive financial developments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

